日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FOXM1-specific TCR-engineered T cells target non-small cell lung cancer

针对FOXM1的TCR工程化T细胞靶向非小细胞肺癌

Bontekoe, Emily; Zhang, Minying; Jiang, Peixin; Montoya, Amanda; Shulga, Yulia; Slone, Jared K; Paul, Emily; Polera, Christopher; Forward, Sarah; Nassif Rausseo, Barbara; Assita, Emane Rose; Xing, Changsheng; Molkentine, David P; Morris, Benjamin B; Polic, Isabella; Roszik, Janos; Salgado, Ricardo; Vaishnavi, Aria; Deniger, Drew; Tran, Hai T; Gibbons, Don L; Vaporciyan, Ara; Gillison, Maura L; Wistuba, Ignacio I; Kavraki, Lydia E; Zhang, Jianjun; Lizee, Gregory; Yee, Cassian; Hwu, Patrick; Kwok, Sheldon; Jaeger, Alex M; Heymach, John V; Reuben, Alexandre

Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer

在非小细胞肺癌中,肿瘤内中性粒细胞与淋巴细胞的比值与循环中性粒细胞与淋巴细胞的比值相对应。

Mitchell, Kyle G; Lee, Younghee; Deboever, Nathaniel; Negrao, Marcelo V; Tran, Hai T; Parra, Edwin; Byers, Lauren; Reuben, Alexandre; Federico, Lorenzo; Bernatchez, Chantale; Wang, Jing; Antonoff, Mara B; Vaporciyan, Ara A; Swisher, Stephen G; Cascone, Tina; Wistuba, Ignacio I; Heymach, John V; Gibbons, Don L; Zhang, Jianjun; McGrail, Daniel J; Sepesi, Boris; Haymaker, Cara L

Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas

极光激酶 A 抑制剂 Alisertib 和 Pembrolizumab 治疗难治性、Rb 缺乏的头颈鳞状细胞癌的 I/II 期研究

Johnson, Faye M; O'Hara, Madison P; Yapindi, Lacin; Jiang, Peixin; Tran, Hai T; Reuben, Alexandre; Xiao, Weihong; Gillison, Maura L; Sun, Xiaowen; Khalaf, Alexander; Lee, J Jack; Sastry, Jagannadha K; Ghosh, Soma

MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer

MET 过表达与晚期非小细胞肺癌患者免疫治疗获益增强相关

Li, Hui; Hong, Lingzhi; Rocha, Pedro; Bach, Rafael; Solis Soto, Luisa M; Rinsurongkawong, Waree; Zhang, Bingnan; Araujo, Haniel A; Elamin, Yasir Y; Altan, Mehmet; Arrechedera, Claudio A; Zhou, Jianling; Khan, Khaja B; Lu, Wei; Young, Elliana; Gay, Carl M; Cascone, Tina; Byers, Lauren A; Skoulidis, Ferdinandos; Blumenschein, George; Fossella, Frank V; Tsao, Anne; Negrao, Marcelo V; Vokes, Natalie; Wu, Jia; Tran, Hai T; Wistuba, Ignacio I; Lee, J Jack; Gibbons, Don L; Vaporciyan, Ara A; Heymach, John V; Le, Xiuning; Zhang, Jianjun

Longitudinal Tracking of ALK-Rearranged NSCLC From Plasma Using Circulating Tumor RNA and Circulating Tumor DNA

利用循环肿瘤RNA和循环肿瘤DNA对血浆中ALK重排的非小细胞肺癌进行纵向追踪

Heeke, Simon; Gandhi, Saumil; Tran, Hai T; Lam, Vincent K; Byers, Lauren A; Gibbons, Don L; Gay, Carl M; Altan, Mehmet; Antonoff, Mara B; Le, Xiuning; Tu, Janet; Saad, Maliazurina B; Pek, Michelle; Poh, Jonathan; Ngeow, Kao Chin; Tsao, Anne; Cascone, Tina; Negrao, Marcelo V; Wu, Jia; Blumenschein, George R Jr; Heymach, John V; Elamin, Yasir Y

Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights

利用PET/CT显像、ctDNA和整合放射基因组学-血液学信息增强非小细胞肺癌复发预测

Sujit, Sheeba J; Aminu, Muhammad; Karpinets, Tatiana V; Chen, Pingjun; Saad, Maliazurina B; Salehjahromi, Morteza; Boom, John D; Qayati, Mohamed; George, James M; Allen, Haley; Antonoff, Mara B; Hong, Lingzhi; Hu, Xin; Heeke, Simon; Tran, Hai T; Le, Xiuning; Elamin, Yasir Y; Altan, Mehmet; Vokes, Natalie I; Sheshadri, Ajay; Lin, Julie; Zhang, Jianhua; Lu, Yang; Behrens, Carmen; Godoy, Myrna C B; Wu, Carol C; Chang, Joe Y; Chung, Caroline; Jaffray, David A; Wistuba, Ignacio I; Lee, J Jack; Vaporciyan, Ara A; Gibbons, Don L; Heymach, John; Zhang, Jianjun; Cascone, Tina; Wu, Jia

High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC

外周T细胞多样性高与转移性非小细胞肺癌患者毒性风险降低和对双重免疫检查点抑制剂治疗的疗效更佳相关。

Altan, Mehmet; Li, Ruoxing; Li, Ziyi; Chen, Runzhe; Sheshadri, Ajay; Tran, Hai T; Little, Latasha; Baguley, Joshua; Sinson, Jefferson; Vokes, Natalie; Gandhi, Saumil; Antonoff, Mara B; Swisher, Stephen G; Lizee, Greg; Reuben, Alexandre; Heymach, John V; Zhang, Jianjun

Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events

与器官特异性免疫相关不良事件相关的自身反应性抗体的独特模式

Altan, Mehmet; Li, Quan-Zhen; Wang, Qi; Vokes, Natalie I; Sheshadri, Ajay; Gao, Jianjun; Zhu, Chengsong; Tran, Hai T; Gandhi, Saumil; Antonoff, Mara B; Swisher, Stephen; Wang, Jing; Byers, Lauren A; Abdel-Wahab, Noha; Franco-Vega, Maria C; Wang, Yinghong; Lee, J Jack; Zhang, Jianjun; Heymach, John V

A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation

一项针对携带 EGFR 突变/扩增、HER2 突变/扩增、HER3/4 突变或 KRAS 突变的晚期癌症患者的 I 期临床试验,评估了泛 ERBB 抑制剂奈拉替尼联合 MEK 抑制剂曲美替尼的疗效。

Piha-Paul, Sarina A; Tseng, Chieh; Tran, Hai T; Gao, Meng; Karp, Daniel D; Subbiah, Vivek; Tsimberidou, Apostolia Maria; Kawedia, Jitesh D; Fu, Siqing; Pant, Shubham; Yap, Timothy A; Morris, Van K; Kee, Bryan K; Blum Murphy, Mariela; Lim, JoAnn; Meric-Bernstam, Funda

Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC

晚期非小细胞肺癌患者循环肿瘤DNA水平的基因型特异性差异

Lam, Vincent K; Zhang, Jianjun; Wu, Carol C; Tran, Hai T; Li, Lerong; Diao, Lixia; Wang, Jing; Rinsurongkawong, Waree; Raymond, Victoria M; Lanman, Richard B; Lewis, Jeff; Roarty, Emily B; Roth, Jack; Swisher, Stephen; Lee, J Jack; Gibbons, Don L; Papadimitrakopoulou, Vassiliki A; Heymach, John V